Pharmacists to begin recommending Respiri’s wheezo asthma management device

Respiri (ASX:RSH) is taking a big step forward with an agreement for its Pharmacy Catalyst members to sell its wheezo … Read More

The post Pharmacists to begin recommending Respiri’s wheezo asthma management device appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *